• Không có kết quả nào được tìm thấy

to develop. Preparations that swell in contact with liquid should always be carefully swallowed with water and should not be taken immediately before going to bed.

lMEDICINAL FORMS

There can be variation in the licensing of different medicines containing the same drug.

Tablet

Celevac(AMCo)

Methylcellulose "450" 500 mgCelevac500mg tablets|112 tabletG £3.22DT price = £3.22

Sterculia

19-Feb-2016

lDRUG ACTIONSterculia is a bulk-forming laxative. It relieves constipation by increasing faecal mass which stimulates peristalsis.

lINDICATIONS AND DOSE Constipation

▶BY MOUTH

Child 6–11 years:0.5–1sachet1–2times a day, alternatively, half to one heaped5-mL spoonful once or twice a day; washed down without chewing with plenty of liquid after meals

Child 12–17 years:1–2sachets1–2times a day, alternatively, one to two heaped5-mL spoonfuls once or twice a day; washed down without chewing with plenty of liquid after meals

Adult:1–2sachets1–2times a day, alternatively, one to two heaped5-mL spoonfuls once or twice a day;

washed down without chewing with plenty of liquid after meals

lCONTRA-INDICATIONSColonic atony

.

difficulty in swallowing

.

faecal impaction

.

intestinal obstruction lCAUTIONSAdequatefluid intake should be maintained to

avoid intestinal obstruction CAUTIONS, FURTHER INFORMATION

In adultsIt may be necessary to supervise elderly or debilitated patients or those with intestinal narrowing or decreased motility to ensure adequatefluid intake.

lSIDE-EFFECTSAbdominal distension (especially during thefirst few days of treatment)

.

flatulence (especially during thefirst few days of treatment)

.

gastro-intestinal impaction

.

gastro-intestinal obstruction

.

hypersensitivity lDIRECTIONS FOR ADMINISTRATIONMay be mixed with soft food (e.g. yoghurt) before swallowing, followed by plenty of liquid.

lPATIENT AND CARER ADVICEPatients and their carers should be advised that the full effect may take some days to develop. Preparations that swell in contact with liquid should always be carefully swallowed with water and should not be taken immediately before going to bed.

lMEDICINAL FORMS

There can be variation in the licensing of different medicines containing the same drug.

Granules

CAUTIONARY AND ADVISORY LABELS25, 27

Normacol(Norgine Pharmaceuticals Ltd)

Sterculia 620 mg per 1 gramNormacol granules7g sachets|60 sachetG £6.35DT price = £6.35

Normacol granules|500gramG£7.54DT price = £7.54

Sterculia with frangula

The properties listed below are those particular to the combination only. For the properties of the components please consider, sterculia above.

lINDICATIONS AND DOSE After haemorrhoidectomy

▶BY MOUTH

Adult:1–2sachets1–2times a day, alternatively,1–2 heaped5mL spoonfuls once or twice a day; washed down without chewing with plenty of liquid after meals Constipation

▶BY MOUTH

Adult:1–2sachets1–2times a day, alternatively,1–2 heaped5mL spoonfuls once or twice a day; washed down without chewing with plenty of liquid after meals

lPREGNANCYManufacturer advises avoid.

lBREAST FEEDINGManufacturer advises avoid.

lPATIENT AND CARER ADVICEPatients and their carers should be advised that the full effect may take some days to develop. Preparations that swell in contact with liquid should always be carefully swallowed with water and should not be taken immediately before going to bed.

lMEDICINAL FORMS

There can be variation in the licensing of different medicines containing the same drug.

Granules

Normacol Plus(Norgine Pharmaceuticals Ltd) Frangula 80 mg per 1 gram, Sterculia 620 mg per

1 gramNormacol Plus granules7g sachets|60sachetG£6.78 DT price = £6.78

Normacol Plus granules|500gramG£8.05DT price = £8.05

LAXATIVES

CHLORIDE-CHANNEL AGONISTS

Lubiprostone

23-Mar-2016

lNATIONAL FUNDING/ACCESS DECISIONS NICE technology appraisals (TAs)

▶Lubiprostone for treating chronic idiopathic constipation (July 2014)NICE TA318

Lubiprostone is recommended as an option for treating chronic idiopathic constipation for adults in whom treatment with at least2laxatives from different classes, at the highest tolerated recommended doses for at least 6months, has failed to provide adequate relief and for whom invasive treatment for constipation is being considered. If treatment with lubiprostone is not effective after2weeks, the patient should be re-examined and the benefit of continuing treatment reconsidered.

Lubiprostone should only be prescribed by a clinician with experience of treating chronic idiopathic

constipation, after careful review of the patient’s previous courses of laxative treatments.

www.nice.org.uk/TA318

Scottish Medicines Consortium (SMC) Decisions TheScottish Medicines Consortiumhas advised (July2014) that lubiprostone (Amitiza)®isnotrecommended for use within NHS Scotland.

lMEDICINAL FORMS

There can be variation in the licensing of different medicines containing the same drug.

Capsule

CAUTIONARY AND ADVISORY LABELS21

Amitiza(Sucampo Pharma Europe Ltd)A

Lubiprostone 24 microgramAmitiza24microgram capsules|28 capsuleP £29.68|56capsuleP£53.48

LAXATIVES

OSMOTIC LAXATIVES

Lactulose

lINDICATIONS AND DOSE Constipation

▶BY MOUTH

Child 1–11 months:2.5mL twice daily, adjusted according to response

Child 1–4 years:2.5–10mL twice daily, adjusted according to response

Child 5–17 years:5–20mL twice daily, adjusted according to response

Adult:Initially15mL twice daily, adjusted according to response

Hepatic encephalopathy (portal systemic encephalopathy)

▶BY MOUTH

Adult:Adjusted according to response to30–50mL 3times a day, subsequently adjusted to produce2–3 soft stools per day

PHARMACOKINETICS

Lactulose may take up to48hours to act.

lUNLICENSED USE

In adultsLactulose doses in the BNF may differ from those in product literature.

lCONTRA-INDICATIONSGalactosaemia

.

intestinal obstruction

lCAUTIONSLactose intolerance lSIDE-EFFECTS

▶Common or very commonAbdominal discomfort

.

cramps

.

flatulence

.

nausea

.

vomiting SIDE-EFFECTS, FURTHER INFORMATION

NauseaNausea can be reduced by administration with water, fruit juice or meals.

lPREGNANCYNot known to be harmful.

lPATIENT AND CARER ADVICE

Medicines for Children leaflet: Lactulose for constipation www.medicinesforchildren.org.uk/lactulose-for-constipation

lMEDICINAL FORMS

There can be variation in the licensing of different medicines containing the same drug.

Oral solution

Lactulose (Non-proprietary)

Lactulose 666.667 mg per 1 mlLactulose10g/15ml oral solution 15ml sachets sugar free sugar-free|10sachetp £2.50DT price =

£2.50

Lactulose 680 mg per 1 mlLactulose3.1-3.7g/5ml oral solution| 300mlp£2.73|500mlp£4.55DT price = £2.52

Duphalac(Mylan Ltd)

Lactulose 680 mg per 1 mlDuphalac3.35g/5ml syrup|200mlp

£1.92

Lactugal(Intrapharm Laboratories Ltd)

Lactulose 680 mg per 1 mlLactugal3.1-3.7g/5ml oral solution| 500mlp£4.56DT price = £2.52|2000mlp £16.42

Macrogol 3350 with potassium chloride, sodium bicarbonate and sodium chloride

lINDICATIONS AND DOSE

Chronic constipation (dose for non-proprietary’ full-strength’sachets)

▶BY MOUTH

Child 12–17 years:1–3sachets daily in divided doses usually for up to2weeks; maintenance1–2sachets daily

Adult:1–3sachets daily in divided doses usually for up to2weeks; maintenance1–2sachets daily

Faecal impaction (dose for non-proprietary’full-strength’ sachets)

▶BY MOUTH

Child 12–17 years:4sachets onfirst day, then increased in steps of2sachets daily, total daily dose to be drunk within a6hour period, after disimpaction, switch to maintenance laxative therapy if required; maximum 8sachets per day

Adult:4sachets onfirst day, then increased in steps of 2sachets daily, total daily dose to be drunk within a 6hour period, after disimpaction, switch to maintenance laxative therapy if required; maximum 8sachets per day

MOVICOL-HALF® Chronic constipation

▶BY MOUTH

Child 12–17 years:2–6sachets daily in divided doses usually for up to2weeks; maintenance2–4sachets daily

Adult:2–6sachets daily in divided doses usually for up to2weeks; maintenance2–4sachets daily

Faecal impaction

▶BY MOUTH

Child 12–17 years:Initially8sachets daily onfirst day, then increased in steps of4sachets daily, total daily dose to be drunk within6hours, after disimpaction, switch to maintenance laxative therapy; maximum 16sachets per day

Adult:Initially8sachets daily onfirst day, then increased in steps of4sachets daily, total daily dose to be drunk within6hours, after disimpaction, switch to maintenance laxative therapy; maximum16sachets per day

MOVICOL-PAEDIATRIC®

Chronic constipation|Prevention of faecal impaction

▶BY MOUTH

Child 2–5 years:1sachet daily, adjust dose to produce regular soft stools; maximum4sachets per day

continued

BNF74

Constipation 55

Gastro-intestinalsystem

1

Child 6–11 years:2sachets daily, adjust dose to produce regular soft stools; maximum4sachets per day Faecal impaction

▶BY MOUTH

Child 5–11 years:Initially4sachets daily onfirst day, then increased in steps of2sachets daily, total daily dose to be taken over a12-hour period, after disimpaction, switch to maintenance laxative therapy;

maximum12sachets per day MOVICOL®LIQUID

Chronic constipation

▶BY MOUTH

Child 12–17 years:25mL1–3times a day usually for up to2weeks; maintenance25mL1–2times a day

Adult:25mL1–3times a day usually for up to2weeks;

maintenance25mL1–2times a day MOVICOL®ORAL POWDER

Chronic constipation

▶BY MOUTH

Child 12–17 years:1–3sachets daily in divided doses usually for up to2weeks; maintenance1–2sachets daily

Adult:1–3sachets daily in divided doses usually for up to2weeks; maintenance1–2sachets daily

Faecal impaction

▶BY MOUTH

Child 12–17 years:Initially4sachets daily onfirst day, then increased in steps of2sachets daily, total daily dose to be drunk within a6hour period, after disimpaction, switch to maintenance laxative therapy if required; maximum8sachets per day

Adult:Initially4sachets daily onfirst day, then increased in steps of2sachets daily, total daily dose to be drunk within a6hour period, after disimpaction, switch to maintenance laxative therapy if required;

maximum8sachets per day

lUNLICENSED USE

MOVICOL-PAEDIATRIC® Movicol®Paediatricnot licensed for use in faecal impaction in children under5years, or for chronic constipation in children under2years.

lCONTRA-INDICATIONSCrohn’s disease

.

intestinal obstruction

.

intestinal perforation

.

paralytic ileus

.

severe inflammatory conditions of the intestinal tract

.

toxic megacolon

.

ulcerative colitis

MOVICOL-PAEDIATRIC® Cardiovascular impairment

.

renal impairment

lCAUTIONSCardiovascular impairment (should not take more than2’full-strength’sachets or4’half-strength’

sachets in any one hour)

.

discontinue if symptoms offluid and electrolyte disturbance

MOVICOL-PAEDIATRIC® Impaired consciousness (with high doses)

.

impaired gag reflex (with high doses)

.

reflux

oesophagitis (with high doses)

lSIDE-EFFECTSAbdominal distention

.

addominal pain

.

flatulence

.

nausea

lPREGNANCYLimited data, but manufacturer advises that it can be used.

lBREAST FEEDINGManufacturer advises that it can be used.

lRENAL IMPAIRMENT

MOVICOL-PAEDIATRIC® Contra-indicated in renal impairment.

lDIRECTIONS FOR ADMINISTRATIONContents of each’full strength’sachet of oral powder to be dissolved in half a glass (approx.125mL) of water; after reconstitution the solution should be kept in a refrigerator and discarded if unused after6hours.

MOVICOL®LIQUID25mL of oral concentrate to be diluted with half a glass (approx.100mL) of water. After dilution the solution should be discarded if unused after24hours.

MOVICOL-PAEDIATRIC®Contents of each sachet to be dissolved in quarter of a glass (approx.60–65mL) of water;

after reconstitution the solution should be kept in a refrigerator and discarded if unused after24hours.

MOVICOL®ORAL POWDERContents of each sachet to be dissolved in half a glass (approx.125mL) of water; after reconstitution the solution should be kept in a refrigerator and discarded if unused after6hours.

MOVICOL-HALF®Contents of each sachet to be dissolved in quarter of a glass (approx.60–65mL) of water; after reconstitution the solution should be kept in a refrigerator and discarded if unused after6hours.

lPRESCRIBING AND DISPENSING INFORMATIONFlavours of oral liquid formulations may include orange.

Flavours of oral powder formulations may include chocolate, lime and lemon, or plain.

MOVICOL®LIQUID25mL of oral concentrate when diluted with100mL water provides K+5.4mmol/litre.

MOVICOL®ORAL POWDERAmount of potassium chloride varies according toflavour ofMovicol®as follows:

plain-flavour (sugar-free) =50.2mg/sachet; lime and lemonflavour =46.6mg/sachet; chocolateflavour = 31.7mg/sachet.1sachet when reconstituted with125mL water provides K+5.4mmol/litre.

lPATIENT AND CARER ADVICE

Patients or carers should be counselled on how to take the oral powder and oral solution.

Medicines for Children leaflet: Movicol for constipation www.medicinesforchildren.org.uk/movicol-for-constipation MOVICOL®LIQUIDPatients or carers should be counselled on how to takeMovicol®oral solution.

MOVICOL®ORAL POWDERPatients or carers should be counselled on how to takeMovicol®oral powder.

MOVICOL-HALF®Patients or carers should be given advice on how to administerMovicol-Half®oral powder.

lMEDICINAL FORMS

There can be variation in the licensing of different medicines containing the same drug.

Oral solution

CAUTIONARY AND ADVISORY LABELS13

ELECTROLYTES:May contain Bicarbonate, chloride, potassium, sodium

Movicol(Norgine Pharmaceuticals Ltd)

Macrogol’3350’105 gram per 1 litre, Potassium 5.4 mmol per 1 litre, Bicarbonate 17 mmol per 1 litre, Chloride 53 mmol per 1 litre, Sodium 65 mmol per 1 litreMovicol Liquid sugar-free|500 mlp£5.15DT price = £5.15

Powder

CAUTIONARY AND ADVISORY LABELS13

ELECTROLYTES:May contain Bicarbonate, chloride, potassium, sodium

Movicol(Norgine Pharmaceuticals Ltd)

Macrogol’3350’52.5 gram per 1 litre, Potassium 5.4 mmol per 1 litre, Bicarbonate 17 mmol per 1 litre, Chloride 53 mmol per 1 litre, Sodium 65 mmol per 1 litreMovicol-Half oral powder6.9g sachets sugar-free|20sachetp £3.37sugar-free|30sachetp

£5.06DT price = £4.38

Movicol Paediatric Plain oral powder6.9g sachets sugar-free|30 sachetP £4.38DT price = £4.38

Movicol Paediatric Chocolate oral powder6.9g sachets sugar-free|30 sachetP £4.38DT price = £4.38

Macrogol’3350’105 gram per 1 litre, Potassium 5.4 mmol per 1 litre, Bicarbonate 17 mmol per 1 litre, Chloride 53 mmol per 1 litre, Sodium 65 mmol per 1 litreMovicol Plain oral powder13.7g sachets sugar-free|30sachetp £7.72DT price = £4.27sugar-free| 50sachetp£12.85

Movicol Chocolate oral powder13.9g sachets sugar-free|30 sachetp £7.72DT price = £4.27

Movicol oral powder13.8g sachets lemon & lime sugar-free|20 sachetp £5.15sugar-free|30sachetp £7.72DT price = £4.27 sugar-free|50sachetp£12.85

56 Constipation and bowel cleansing

BNF74

Gastro-intestinalsystem

1

Magnesium hydroxide

lINDICATIONS AND DOSE Constipation

▶BY MOUTH

Adult:30–45mL as required, dose to be given mixed with water at bedtime

lCONTRA-INDICATIONSAcute gastro-intestinal conditions lCAUTIONSDebilitated patients

.

elderly

lINTERACTIONS→Appendix1: magnesium lSIDE-EFFECTSColic

lHEPATIC IMPAIRMENTAvoid in hepatic coma if risk of renal failure.

lRENAL IMPAIRMENTAvoid or reduce dose. Increased risk of toxicity in renal impairment.

lPRESCRIBING AND DISPENSING INFORMATIONWhen prepared extemporaneously, the BP states Magnesium Hydroxide Mixture, BP consists of an aqueous suspension containing about8% hydrated magnesium oxide.

lMEDICINAL FORMS

There can be variation in the licensing of different medicines containing the same drug.

Oral suspension

Phillips’Milk of Magnesia(Omega Pharma Ltd)

Magnesium hydroxide 83 mg per 1 mlPhillips’Milk of Magnesia 415mg/5ml oral suspension sugar-free|200mlG£3.22DT price

= £3.22

Combinations available:Liquid paraffin with magnesium hydroxide,p.59

Sodium acid phosphate with sodium phosphate

lINDICATIONS AND DOSE

Constipation (using Phosphates Enema BP Formula B)| Bowel evacuation before abdominal radiological procedures, endoscopy, and surgery (using Phosphates Enema BP Formula B)

▶BY RECTUM

Child 3–6 years:45–65mL once daily

Child 7–11 years:65–100mL once daily

Child 12–17 years:100–128mL once daily

Adult:128mL daily FLEET®READY-TO-USE ENEMA

Constipation|Bowel evacuation before abdominal radiological procedures|Bowel evacuation before endoscopy|Bowel evacuation before surgery

▶BY RECTUM

Adult:118mL FLEET®PHOSPHO-SODA

Bowel evacuation before colonic surgery|Bowel evacuation before colonoscopy|Bowel evacuation before radiological examination

▶BY MOUTH

Adult:45mL twice daily, each dose must be diluted with half a glass (120mL) of cold water, followed by one full glass (240mL) of cold water, timing of doses is dependent on the time of the procedure, for morning procedure, thefirst dose should be taken at7a.m. and second at7p.m. on day before the procedure.; for afternoon procedure,first dose should be taken at 7p.m. on day before and second dose at7a.m. on day of the procedure

PHARMACOKINETICS

ForFleet®Phospho-soda:Onset of action is within half to 6hours offirst dose.

lCONTRA-INDICATIONS

With oral useAcute severe colitis

.

ascites

.

congestive cardiac failure

.

gastric retention

.

gastro-intestinal obstruction

.

gastro-intestinal perforation

.

toxic megacolon

With rectal useConditions associated with increased colonic absorption

.

gastro-intestinal obstruction

.

inflammatory bowel disease lCAUTIONS

With oral useCardiac disease (avoid in congestive cardiac failure)

.

colitis (avoid if acute severe colitis)

.

elderly and debilitated patients

.

fluid and electrolyte disturbances

.

hypovolaemia (should be corrected before administration)

.

impaired gag reflex or possibility of regurgitation or aspiration

With rectal useAscites

.

congestive heart failure

.

elderly and debilitated patients

.

electrolyte disturbances

.

uncontrolled hypertension

lINTERACTIONS→Appendix1: bowel cleansing preparations

lSIDE-EFFECTS

▶Common or very common

With oral useAbdominal distention

.

abdominal pain (usually transient—reduced by taking more slowly)

.

nausea

.

vomiting

▶Uncommon

With oral useDehydration

.

dizziness

.

headache

▶Frequency not known

With oral useArrhythmias

.

asthenia

.

chest pain

.

electrolyte disturbances

.

renal failure

With rectal useElectrolyte disturbances

.

local irritation lPREGNANCY

With oral useCaution.

lBREAST FEEDING

With oral useCaution.

lHEPATIC IMPAIRMENTUse with caution in cirrhosis.

lRENAL IMPAIRMENT

With oral useAvoid if eGFR less than 60mL/minute/1.73m2.

With rectal useUse with caution.

lMONITORING REQUIREMENTS

With oral useRenal function should be measured before starting treatment in patients at risk offluid and electrolyte disturbances.

lDIRECTIONS FOR ADMINISTRATION

FLEET®PHOSPHO-SODACopious intake of water or other clearfluids (e.g. clear soup, strained fruit juice without pulp, black tea or coffee) recommended until midnight before morning procedure and until8a.m. before afternoon procedure. At least one glass (approx240mL) of water or other clearfluid should also be taken immediately before each dose.

lPRESCRIBING AND DISPENSING INFORMATIONWhen prepared extemporaneously, the BP states Phosphates Enema BP Formula B consists of sodium dihydrogen phosphate dihydrate12.8g, disodium phosphate dodecahydrate10.24g, purified water, freshly boiled and cooled, to128mL.

lPATIENT AND CARER ADVICE

FLEET®PHOSPHO-SODAIntake of solid food should be stopped for at least6hours before starting treatment and until procedure completed.

Patients or carers should be advised that adequate hydration should be maintained during treatment.

Patients or carers should be given advice on administration ofFleet Phospho-soda®oral solution.

BNF74

Constipation 57

Gastro-intestinalsystem

1

lMEDICINAL FORMS

There can be variation in the licensing of different medicines containing the same drug.

Oral solution

CAUTIONARY AND ADVISORY LABELS10 ELECTROLYTES:May contain Phosphate, sodium

Fleet Phospho-soda(Casen Recordati S.L.)

Disodium hydrogen phosphate dodecahydrate 240 mg per 1 ml, Sodium dihydrogen phosphate dihydrate 542 mg per 1 mlFleet Phospho-soda oral solution sugar-free|90mlp £4.79 Enema

Sodium acid phosphate with sodium phosphate (Non-proprietary)

Disodium hydrogen phosphate dodecahydrate 80 mg per 1 ml, Sodium dihydrogen phosphate dihydrate 100 mg per 1 mlPhosphates enema (Formula B)128ml long tube|1enemap

£27.93DT price = £27.93

Phosphates enema (Formula B)128ml standard tube|1enemap

£3.98DT price = £3.98

Fleet Ready-to-use(Casen Recordati S.L.)

Disodium hydrogen phosphate dodecahydrate 80 mg per 1 ml, Sodium dihydrogen phosphate dihydrate 181 mg per 1 mlCleen Ready-to-use133ml enema|1enemap£0.68

LAXATIVES

SELECTIVE 5-HT4RECEPTOR AGONISTS

Prucalopride

24-Feb-2016